about
A high confidence, manually validated human blood plasma protein reference setCovalent inactivation of factor VIII antibodies from hemophilia A patients by an electrophilic FVIII Analog.Exceptional amyloid beta peptide hydrolyzing activity of nonphysiological immunoglobulin variable domain scaffolds.Beneficial catalytic immunity to abeta peptide.Physiological IgM class catalytic antibodies selective for transthyretin amyloid.High levels of catalytic antibodies correlate with favorable outcome in sepsis.Covalent binding antibodies suppress advanced glycation: on the innate tier of adaptive immunity.Back to the future: covalent epitope-based HIV vaccine development.IVIg treatment reduces catalytic antibody titers of renal transplanted patientsAutoantibodies with enzymatic properties in human autoimmune diseases.Constitutive production of catalytic antibodies to a Staphylococcus aureus virulence factor and effect of infection.Metal-dependent amyloid β-degrading catalytic antibody construct.Deficient synthesis of class-switched, HIV-neutralizing antibodies to the CD4 binding site and correction by electrophilic gp120 immunogen.Constant domain-regulated antibody catalysis.Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24Catalytic antibodies to amyloid beta peptide in defense against Alzheimer disease.Generation of Catalytic Antibodies Is an Intrinsic Property of an Individual's Immune System: A Study on a Large Cohort of Renal Transplant Patients.Toward effective HIV vaccination: induction of binary epitope reactive antibodies with broad HIV neutralizing activity.Antigen-specific proteolysis by hybrid antibodies containing promiscuous proteolytic light chains paired with an antigen-binding heavy chain.Do proteolytic antibodies complete the panoply of the autoimmune response in acquired haemophilia A?A Monoclonal Antibody to Cryptococcus neoformans Glucuronoxylomannan Manifests Hydrolytic Activity for Both Peptides and Polysaccharides.Crystal structure of a glycosylated Fab from an IgM cryoglobulin with properties of a natural proteolytic antibody.Mutations to Cysteine Residues in the Trypanosoma cruzi B-Cell Superantigen Tc24 Diminish Susceptibility to IgM-Mediated Hydrolysis.Antibody-Mediated Catalysis in Infection and Immunity.A human germ line antibody light chain with hydrolytic properties associated with multimerization status.Toward selective covalent inactivation of pathogenic antibodies: a phosphate diester analog of vasoactive intestinal peptide that inactivates catalytic autoantibodies.Towards covalent vaccination: improved polyclonal HIV neutralizing antibody response induced by an electrophilic gp120 V3 peptide analog.Autoantibody-catalyzed hydrolysis of amyloid beta peptide.Emerging therapeutic targets currently under investigation for the treatment of systemic amyloidosis.Catalytic antibodies from HIV-infected patients specifically hydrolyzing viral integrase suppress the enzyme catalytic activities
P2860
Q28756902-E5AC9251-592A-478D-842D-92B3CAA7B515Q30481770-AFA279E8-F040-4678-B3FE-72D46E5D90C7Q33381465-2491266D-AD91-4786-924E-DFA3CDC13D36Q33549900-B253D28B-CFFD-4CEE-AA70-95283D7E4778Q33676625-C495CDE3-14E4-4BB2-A5C6-13076E30FD3CQ33932633-12D425F2-E900-417D-A6A8-FA68DA4CDC15Q34287672-B29D74A4-719A-4C42-8BD8-6D723E59D506Q34597300-858FA5DF-A5FF-45AD-826A-14FA172DABEBQ34962680-EBA2502A-10E7-4E1A-A8F7-91957AC62ADAQ35214200-D3388EC3-9ED3-46A4-954A-574CD654FBEEQ35880109-485FEE2E-073F-4473-87BC-B6FA15F39098Q35882013-7C756243-CADD-4FF3-BDB3-88DDDF578864Q36069818-41005578-282C-4008-8D2F-DCC14143FCC1Q36332826-82585432-BFBC-4381-BFC9-435AFE15B69EQ36455741-494878F2-97A0-4506-82D0-D0D80C821DC5Q36724775-156FE653-32F4-4021-81B8-44E951278EBAQ36905946-9B559FDB-F85A-4266-9BB0-40FB2CDA050CQ37431843-D76F739C-4177-4575-BFE1-6FA9E7158778Q37433442-82B6DEE8-5231-417F-8708-C7A52F891EEFQ37944291-C59BF8A4-FDCD-485F-960F-3805CEB0EC72Q38290090-05A1C9AD-09F9-4416-B579-640072DA5F58Q38316632-1B8F96D1-D174-420C-9850-9F1BCB1F2269Q38743675-E5432B23-4908-4047-9240-8DE504BFB708Q39412526-7CD522D7-A399-4A07-87DA-84F9D8BFA04EQ42680119-CAAD8171-7A2D-483E-B43F-BC8B1EF9C324Q44693889-4505B49D-49AF-41F7-B96B-3CC68059AB2CQ44745703-CD9EC946-C3BE-4A59-89DB-9858F676780EQ46845401-6ABA2260-B545-41E2-9F08-37C2F00AFA7DQ47404960-181DA742-4F7A-4A99-A33B-FFB820CC5AD4Q59084568-0C96F924-1621-4C10-A23C-35EEEC04608C
P2860
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh
2004年學術文章
@zh-hant
name
Ontogeny of proteolytic immunity: IgM serine proteases.
@en
Ontogeny of proteolytic immunity: IgM serine proteases.
@nl
type
label
Ontogeny of proteolytic immunity: IgM serine proteases.
@en
Ontogeny of proteolytic immunity: IgM serine proteases.
@nl
prefLabel
Ontogeny of proteolytic immunity: IgM serine proteases.
@en
Ontogeny of proteolytic immunity: IgM serine proteases.
@nl
P2093
P2860
P356
P1476
Ontogeny of proteolytic immunity: IgM serine proteases.
@en
P2093
Allen Edmundson
Brian Poindexter
Hiroaki Taguchi
Roger Bick
Sangeeta Karle
Stephanie Planque
Sudhir Paul
Xiao-Tong Song
Yasuhiro Nishiyama
Yogesh Bangale
P2860
P304
14024-14032
P356
10.1074/JBC.M312152200
P407
P577
2004-01-15T00:00:00Z